| Literature DB >> 33911397 |
Prateek Kumar Panda1, Indar Kumar Sharawat1, Shinjini Choudhury2.
Abstract
Entities:
Year: 2020 PMID: 33911397 PMCID: PMC8061516 DOI: 10.4103/aian.AIAN_147_20
Source DB: PubMed Journal: Ann Indian Acad Neurol ISSN: 0972-2327 Impact factor: 1.383
Comparison of demographic, clinical and laboratory features of various published cases of seizures after heroin withdrawal
| Variables | Total number of published cases with seizures after heroin withdrawal (n-11) | Index patient |
|---|---|---|
| Age (in years) | 20 to 38 | 16 |
| Sex | Male (11/11) | Male |
| Country of origin | India (10/11), Sri Lanka (1) | India |
| Duration of Heroin abuse | 2-6 years in Indian patients, 15 years in patient from Sri Lanka | Eight months |
| Time interval between abstinence and seizures | 2-6 days | 3 days |
| Primary mode of consumption | Inhalation/Intravenous | Inhalation |
| Variety of Heroin used | Street variety in all (? contaminated with adulterants) | Street variety (? contaminated with adulterants) |
| Other psychoactive substance use | Benzodiazepine (1) Alcohol (0) | None |
| Seizure semiology | Generalized tonic-clonic | Generalized tonic-clonic |
| Number of seizures | 1 to 10 episodes | 4 episodes |
| Antiepileptic drug used | Valproate and Benzodiazepine | Valproate and Benzodiazepine |
| Duration of antiepileptic drug | Few days to few weeks | Four days |
| Presence of associated delirium | 6/11 | Yes |
| Drugs used for opioid dependence | Dextropropoxyphene, Methadone, Clonidine, Haloperidol, Buprenorphine | Haloperidol, Methadone |
| Urine drug screen result | Radioimmunoassay positive in 7/11 (urinary opioid level 0-2000 ng/dl) | 6-acetylmorphine (qualitative test) |
| Neuroimaging (CT/MRI) | Normal (11/11) | Normal |
| EEG | Normal (10/11), Diffuse cortical dysfunction (1) | Mild diffuse slowing without any epileptiform activity |
| Seizure recurrence in follow-up | No (11/11) | No (3 months follow up) |
| Any neurological sequelae in follow-up | No (11/11) | No |